quizartinib
daiichi sankyo
['quizartinib', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)', 'aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)']
erba et al. phase 3 trial quizartinib os combined
with standard induction and consolidation tx in pts ages 18-75 w/ newly dx flt3-itd+ aml potential to change the standard of care for the tx of adult
patients with newly diagnosed flt3-itd+ aml #amlsm #eha2022 #eha22 
Senior researcher (@IKNL, @ErasmusMC, @AmsterdamUMC) leading population-based cancer research in the Netherlands. Tweets are my own. #leusm #lymsm #crypto #xrp